These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1313 related articles for article (PubMed ID: 10685740)
1. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma. Weston AP; Badr AS; Topalovski M; Cherian R; Dixon A; Hassanein RS Am J Gastroenterol; 2000 Feb; 95(2):387-94. PubMed ID: 10685740 [TBL] [Abstract][Full Text] [Related]
2. CagA-positive strains of Helicobacter pylori may protect against Barrett's esophagus. Vaezi MF; Falk GW; Peek RM; Vicari JJ; Goldblum JR; Perez-Perez GI; Rice TW; Blaser MJ; Richter JE Am J Gastroenterol; 2000 Sep; 95(9):2206-11. PubMed ID: 11007219 [TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori infection, not gastroesophageal reflux, is the major cause of inflammation and intestinal metaplasia of gastric cardiac mucosa. Goldblum JR; Richter JE; Vaezi M; Falk GW; Rice TW; Peek RM Am J Gastroenterol; 2002 Feb; 97(2):302-11. PubMed ID: 11866266 [TBL] [Abstract][Full Text] [Related]
4. Mucosa-associated lymphoid tissue (MALT) in Barrett's esophagus: prospective evaluation and association with gastric MALT, MALT lymphoma, and Helicobacter pylori. Weston AP; Cherian R; Horvat RT; Lawrinenko V; Dixon A; McGregor D Am J Gastroenterol; 1997 May; 92(5):800-4. PubMed ID: 9149188 [TBL] [Abstract][Full Text] [Related]
5. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma. Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156 [TBL] [Abstract][Full Text] [Related]
6. The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with Barrett's esophagus in Japan. Abe Y; Ohara S; Koike T; Sekine H; Iijima K; Kawamura M; Imatani A; Kato K; Shimosegawa T Am J Gastroenterol; 2004 Jul; 99(7):1213-21. PubMed ID: 15233656 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of Helicobacter pylori infection in 160 patients with Barrett's oesophagus or Barrett's adenocarcinoma. Lord RV; Frommer DJ; Inder S; Tran D; Ward RL Aust N Z J Surg; 2000 Jan; 70(1):26-33. PubMed ID: 10696939 [TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori, ethnicity, and the gastroesophageal reflux disease spectrum: a study from the East. Rajendra S; Ackroyd R; Robertson IK; Ho JJ; Karim N; Kutty KM Helicobacter; 2007 Apr; 12(2):177-83. PubMed ID: 17309756 [TBL] [Abstract][Full Text] [Related]
10. Barrett's esophagus and the presence of Helicobacter pylori. Henihan RD; Stuart RC; Nolan N; Gorey TF; Hennessy TP; O'Morain CA Am J Gastroenterol; 1998 Apr; 93(4):542-6. PubMed ID: 9576445 [TBL] [Abstract][Full Text] [Related]
11. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up. Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182 [TBL] [Abstract][Full Text] [Related]
12. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus. Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565 [TBL] [Abstract][Full Text] [Related]
13. Intestinal metaplasia of the gastric cardia. Morales TG; Sampliner RE; Bhattacharyya A Am J Gastroenterol; 1997 Mar; 92(3):414-8. PubMed ID: 9068460 [TBL] [Abstract][Full Text] [Related]
14. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia. Anandasabapathy S; Jhamb J; Davila M; Wei C; Morris J; Bresalier R Cancer; 2007 Feb; 109(4):668-74. PubMed ID: 17211862 [TBL] [Abstract][Full Text] [Related]
15. Colonization with cagA-positive Helicobacter pylori strains in intestinal metaplasia of the esophagus and the esophagogastric junction. Ackermark P; Kuipers EJ; Wolf C; Breumelhof R; Seldenrijk CA; Timmer R; Segeren KC; Kusters JG; Smout AJ Am J Gastroenterol; 2003 Aug; 98(8):1719-24. PubMed ID: 12907324 [TBL] [Abstract][Full Text] [Related]
16. Preservation of gastric acid secretion may be important for the development of gastroesophageal junction adenocarcinoma in Japanese people, irrespective of the H. pylori infection status. Inomata Y; Koike T; Ohara S; Abe Y; Sekine H; Iijima K; Ariizumi K; Yamagishi H; Kitagawa Y; Imatani A; Shimosegawa T Am J Gastroenterol; 2006 May; 101(5):926-33. PubMed ID: 16573782 [TBL] [Abstract][Full Text] [Related]
17. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD]. Endzinas Z; Mickevicius A; Kiudelis M Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039 [TBL] [Abstract][Full Text] [Related]
18. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma. Weston AP; Badr AS; Hassanein RS Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296 [TBL] [Abstract][Full Text] [Related]
19. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus. Katz D; Rothstein R; Schned A; Dunn J; Seaver K; Antonioli D Am J Gastroenterol; 1998 Apr; 93(4):536-41. PubMed ID: 9576444 [TBL] [Abstract][Full Text] [Related]
20. Systematic four-quadrant biopsy detects Barrett's dysplasia in more patients than nonsystematic biopsy. Abela JE; Going JJ; Mackenzie JF; McKernan M; O'Mahoney S; Stuart RC Am J Gastroenterol; 2008 Apr; 103(4):850-5. PubMed ID: 18371135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]